189 related articles for article (PubMed ID: 21692503)
1. Identification of a lacosamide binding protein using an affinity bait and chemical reporter strategy: 14-3-3 ζ.
Park KD; Kim D; Reamtong O; Eyers C; Gaskell SJ; Liu R; Kohn H
J Am Chem Soc; 2011 Jul; 133(29):11320-30. PubMed ID: 21692503
[TBL] [Abstract][Full Text] [Related]
2. Lacosamide isothiocyanate-based agents: novel agents to target and identify lacosamide receptors.
Park KD; Morieux P; Salomé C; Cotten SW; Reamtong O; Eyers C; Gaskell SJ; Stables JP; Liu R; Kohn H
J Med Chem; 2009 Nov; 52(21):6897-911. PubMed ID: 19795888
[TBL] [Abstract][Full Text] [Related]
3. Proteomic searches comparing two (R)-lacosamide affinity baits: An electrophilic arylisothiocyanate and a photoactivated arylazide group.
Park KD; Stables JP; Liu R; Kohn H
Org Biomol Chem; 2010 Jun; 8(12):2803-13. PubMed ID: 20405068
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of novel derivatives of the antiepileptic drug lacosamide that exhibit far greater enhancement in slow inactivation of voltage-gated sodium channels.
Wang Y; Park KD; Salome C; Wilson SM; Stables JP; Liu R; Khanna R; Kohn H
ACS Chem Neurosci; 2011 Feb; 2(2):90-106. PubMed ID: 21532923
[TBL] [Abstract][Full Text] [Related]
5. Discovery of lacosamide affinity bait agents that exhibit potent voltage-gated sodium channel blocking properties.
Park KD; Yang XF; Lee H; Dustrude ET; Wang Y; Khanna R; Kohn H
ACS Chem Neurosci; 2013 Mar; 4(3):463-74. PubMed ID: 23509982
[TBL] [Abstract][Full Text] [Related]
6. Lacosamide derivatives with anticonvulsant activity as carbonic anhydrase inhibitors. Molecular modeling, docking and QSAR analysis.
Garro Martinez JC; Vega-Hissi EG; Andrada MF; Duchowicz PR; Torrens F; Estrada MR
Curr Comput Aided Drug Des; 2014; 10(2):160-7. PubMed ID: 24724895
[TBL] [Abstract][Full Text] [Related]
7. The structure-activity relationship of the 3-oxy site in the anticonvulsant (R)-N-benzyl 2-acetamido-3-methoxypropionamide.
Morieux P; Salomé C; Park KD; Stables JP; Kohn H
J Med Chem; 2010 Aug; 53(15):5716-26. PubMed ID: 20614888
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anticonvulsant activities of N-benzyl (2R)-2-acetamido-3-oxysubstituted propionamide derivatives.
Morieux P; Stables JP; Kohn H
Bioorg Med Chem; 2008 Oct; 16(19):8968-75. PubMed ID: 18789868
[TBL] [Abstract][Full Text] [Related]
9. Drug binding assays do not reveal specific binding of lacosamide to collapsin response mediator protein 2 (CRMP-2).
Wolff C; Carrington B; Varrin-Doyer M; Vandendriessche A; Van der Perren C; Famelart M; Gillard M; Foerch P; Rogemond V; Honnorat J; Lawson A; Miller K
CNS Neurosci Ther; 2012 Jun; 18(6):493-500. PubMed ID: 22672303
[TBL] [Abstract][Full Text] [Related]
10. Chimeric agents derived from the functionalized amino acid, lacosamide, and the α-aminoamide, safinamide: evaluation of their inhibitory actions on voltage-gated sodium channels, and antiseizure and antinociception activities and comparison with lacosamide and safinamide.
Park KD; Yang XF; Dustrude ET; Wang Y; Ripsch MS; White FA; Khanna R; Kohn H
ACS Chem Neurosci; 2015 Feb; 6(2):316-30. PubMed ID: 25418676
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anticonvulsant activities of (R)-N-(4'-substituted)benzyl 2-acetamido-3-methoxypropionamides.
Salomé C; Salomé-Grosjean E; Park KD; Morieux P; Swendiman R; DeMarco E; Stables JP; Kohn H
J Med Chem; 2010 Feb; 53(3):1288-305. PubMed ID: 20041718
[TBL] [Abstract][Full Text] [Related]
12. The anticonvulsant activities of N-benzyl 3-methoxypropionamides.
Andurkar SV; Stables JP; Kohn H
Bioorg Med Chem; 1999 Nov; 7(11):2381-9. PubMed ID: 10632047
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, brain distribution, and plasma protein binding of the antiepileptic drug lacosamide in rats.
Koo TS; Kim SJ; Ha DJ; Baek M; Moon H
Arch Pharm Res; 2011 Dec; 34(12):2059-64. PubMed ID: 22210031
[TBL] [Abstract][Full Text] [Related]
14. The anti-epileptic drug lacosamide (Vimpat) has anxiolytic property in rodents.
Higgins GA; Breysse N; Undzys E; Kuo C; Joharchi N; Derksen DR; Xin T; Isaac M; Slassi M
Eur J Pharmacol; 2009 Dec; 624(1-3):1-9. PubMed ID: 19818346
[TBL] [Abstract][Full Text] [Related]
15. Lacosamide improves outcome in a murine model of traumatic brain injury.
Wang B; Dawson H; Wang H; Kernagis D; Kolls BJ; Yao L; Laskowitz DT
Neurocrit Care; 2013 Aug; 19(1):125-34. PubMed ID: 23269559
[TBL] [Abstract][Full Text] [Related]
16. Effects of the anticonvulsant lacosamide compared to valproate and lamotrigine on cocaine-enhanced reward in rats.
Béguin C; Potter DN; Carlezon WA; Stöhr T; Cohen BM
Brain Res; 2012 Oct; 1479():44-51. PubMed ID: 22940183
[TBL] [Abstract][Full Text] [Related]
17. Effects of the novel antiepileptic drug lacosamide on the development of amygdala kindling in rats.
Brandt C; Heile A; Potschka H; Stoehr T; Löscher W
Epilepsia; 2006 Nov; 47(11):1803-9. PubMed ID: 17116018
[TBL] [Abstract][Full Text] [Related]
18. Lacosamide, the new anticonvulsant, effectively reduces harmaline-induced tremors in rats.
Stöhr T; Lekieffre D; Freitag J
Eur J Pharmacol; 2008 Jul; 589(1-3):114-6. PubMed ID: 18585381
[TBL] [Abstract][Full Text] [Related]
19. Current understanding of the mechanism of action of the antiepileptic drug lacosamide.
Rogawski MA; Tofighy A; White HS; Matagne A; Wolff C
Epilepsy Res; 2015 Feb; 110():189-205. PubMed ID: 25616473
[TBL] [Abstract][Full Text] [Related]
20. Stereoselective effects of the novel anticonvulsant lacosamide against 4-AP induced epileptiform activity in rat visual cortex in vitro.
Lees G; Stöhr T; Errington AC
Neuropharmacology; 2006 Jan; 50(1):98-110. PubMed ID: 16225894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
